miR-183-96-182 Cluster Is Overexpressed in Prostate Tissue and Regulates Zinc Homeostasis in Prostate Cells*

Background: Zinc is vital to normal prostate function and uniquely concentrates in healthy prostate. A hallmark of prostate cancers is diminished zinc levels. Results: The miR-183 family is overexpressed in prostate cancer and regulates intracellular zinc via suppression of zinc transporters. Conclusion: Prostatic zinc homeostasis is regulated by microRNAs. Significance: The miR-183 family regulates zinc and may contribute to prostate carcinogenesis. Decreased zinc levels are a hallmark of prostate cancer tumors as zinc uniquely concentrates in healthy prostate tissue. Increased dietary zinc correlates with decreased risk of advanced prostate cancer and decreased mortality from prostate cancer. The mechanisms of prostatic zinc homeostasis are not known. Lower zinc levels in the tumor are correlated directly with decreased expression of the zinc transporter hZIP1. We report identification of a microRNA cluster that regulates multiple zinc transporters, including hZIP1. Screening in laser capture microdissected prostate cancer tumors identified miR-182 as a potential regulator of hZIP1. Regulation of hZIP1 by miR-182 via two binding sites was confirmed in primary prostate cell cultures. miR-96 and miR-183 are expressed as a cluster with miR-182 and share similar sequences. Array profiling of tissue showed that miR-183, -96, and -182 are higher in prostate cancer tissue compared with normal prostate. Overexpression of the entire miR-183-96-182 cluster suppressed five additional zinc transporters. Overexpression of miR-183, -96, and -182 individually or as a cluster diminished labile zinc pools and reduced zinc uptake, demonstrating this miR cluster as a regulator of zinc homeostasis. We observed regulation of zinc homeostasis by this cluster in prostate cells and HEK-293 cells, suggesting a universal mechanism that is not prostate-specific. To our knowledge, this is the first report of a miR cluster targeting a family of metal transport proteins. Individually or as a cluster, miR-183, -96, and -182 are overexpressed in other cancers too, implicating this miR cluster in carcinogenesis.

[1]  Subbaya Subramanian,et al.  MicroRNA miR-183 functions as an oncogene by targeting the transcription factor EGR1 and promoting tumor cell migration. , 2010, Cancer research.

[2]  D. Polsky,et al.  Aberrant miR-182 expression promotes melanoma metastasis by repressing FOXO3 and microphthalmia-associated transcription factor , 2009, Proceedings of the National Academy of Sciences.

[3]  A. Wolk,et al.  Dietary zinc and prostate cancer survival in a Swedish cohort. , 2011, The American journal of clinical nutrition.

[4]  O. Bagasra,et al.  Zinc and Prostate Cancer: A Critical Scientific, Medical, and Public Interest Issue (United States) , 2005, Cancer Causes & Control.

[5]  Anna Moore,et al.  A novel imaging approach for early detection of prostate cancer based on endogenous zinc sensing. , 2010, Cancer research.

[6]  Fumitaka Osakada,et al.  Targeted deletion of miR-182, an abundant retinal microRNA , 2009, Molecular vision.

[7]  V. Adhami,et al.  Dietary zinc and prostate cancer in the TRAMP mouse model. , 2010, Journal of medicinal food.

[8]  D. Peehl.  Growth of prostatic epithelial and stromal cells in vitro. , 2003, Methods in molecular medicine.

[9]  Chiwai Wong,et al.  A computational screen for mouse signaling pathways targeted by microRNA clusters. , 2008, RNA.

[10]  E. Wentzel,et al.  Cell–cell contact globally activates microRNA biogenesis , 2009, Proceedings of the National Academy of Sciences.

[11]  Guorong Li,et al.  Alterations in microRNA expression in stress-induced cellular senescence , 2009, Mechanisms of Ageing and Development.

[12]  C. Creighton,et al.  Widespread deregulation of microRNA expression in human prostate cancer , 2008, Oncogene.

[13]  C. Burge,et al.  Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.

[14]  D. Valle,et al.  MicroRNA (miRNA) Transcriptome of Mouse Retina and Identification of a Sensory Organ-specific miRNA Cluster* , 2007, Journal of Biological Chemistry.

[15]  O. Bagasra,et al.  hZIP1 zinc uptake transporter down regulation and zinc depletion in prostate cancer , 2005, Molecular Cancer.

[16]  R. Franklin,et al.  Zinc Inhibition of Mitochondrial Aconitase and Its Importance in Citrate Metabolism of Prostate Epithelial Cells* , 1997, The Journal of Biological Chemistry.

[17]  R. Cousins,et al.  Mammalian zinc transporters: nutritional and physiologic regulation. , 2009, Annual review of nutrition.

[18]  Jan Krüger,et al.  RNAhybrid: microRNA target prediction easy, fast and flexible , 2006, Nucleic Acids Res..

[19]  R. Franklin,et al.  hZIP1 zinc transporter down‐regulation in prostate cancer involves the overexpression of ras responsive element binding protein‐1 (RREB‐1) , 2011, The Prostate.

[20]  P. Zalewski,et al.  Cellular zinc fluxes and the regulation of apoptosis/gene-directed cell death. , 2000, The Journal of nutrition.

[21]  Doron Betel,et al.  The microRNA.org resource: targets and expression , 2007, Nucleic Acids Res..

[22]  M. Gorospe,et al.  miR-182-mediated downregulation of BRCA1 impacts DNA repair and sensitivity to PARP inhibitors. , 2011, Molecular cell.

[23]  D. Peehl.  Primary cell cultures as models of prostate cancer development. , 2005, Endocrine-related cancer.

[24]  L. Nonn,et al.  mRNA and micro-RNA expression analysis in laser-capture microdissected prostate biopsies: valuable tool for risk assessment and prevention trials. , 2010, Experimental and molecular pathology.

[25]  G. Kristiansen,et al.  Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma , 2009, International journal of cancer.

[26]  R. Stephens,et al.  Genomic profiling of microRNA and messenger RNA reveals deregulated microRNA expression in prostate cancer. , 2008, Cancer research.

[27]  Taiho Kambe,et al.  Identification of the Zn2+ Binding Site and Mode of Operation of a Mammalian Zn2+ Transporter* , 2009, The Journal of Biological Chemistry.

[28]  B. White,et al.  Coordinate Regulation of FOXO1 by miR-27a, miR-96, and miR-182 in Breast Cancer Cells , 2009, The Journal of Biological Chemistry.

[29]  Hanah Margalit,et al.  Clustering and conservation patterns of human microRNAs , 2005, Nucleic acids research.

[30]  D. Bonci,et al.  MicroRNAs and prostate cancer. , 2010, Endocrine-related cancer.

[31]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[32]  Anton J. Enright,et al.  Human MicroRNA Targets , 2004, PLoS biology.

[33]  F. Habib,et al.  Cancer of the prostate: early diagnosis by zinc and hormone analysis? , 1979, British Journal of Cancer.

[34]  O. Bagasra,et al.  Prostate Cancer in African American Men Is Associated With Downregulation of Zinc Transporters , 2003, Applied immunohistochemistry & molecular morphology : AIMM.

[35]  Kazuya Kawahara,et al.  MiR‐96 and miR‐183 detection in urine serve as potential tumor markers of urothelial carcinoma: correlation with stage and grade, and comparison with urinary cytology , 2011, Cancer science.

[36]  O. Crasta,et al.  Identification of a Common Lupus Disease-Associated microRNA Expression Pattern in Three Different Murine Models of Lupus , 2010, PloS one.

[37]  Libing Song,et al.  Unregulated miR-96 Induces Cell Proliferation in Human Breast Cancer by Downregulating Transcriptional Factor FOXO3a , 2010, PloS one.

[38]  U. Peters,et al.  Zinc Intake From Supplements and Diet and Prostate Cancer , 2009, Nutrition and cancer.

[39]  S. Garrett,et al.  Zinc transporter mRNA expression in the RWPE-1 human prostate epithelial cell line , 2008, BioMetals.

[40]  E. Fridman,et al.  Clinical assessment of the cancer diagnostic value of prostatic zinc: A comprehensive needle‐biopsy study , 2008, The Prostate.